| Rubi Dominguez Rakel, AGACNP-BC | |
|
14300 Orchard Pkwy, Westminster, CO 80023 | |
| (720) 627-3761 | |
| (720) 627-3758 |
| Full Name | Rubi Dominguez Rakel |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 14300 Orchard Pkwy, Westminster, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104590835 | NPI | - | NPPES |
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
In investigating the complex neurocircuitry behind weight gain and glucose control, scientists have known that the hormone leptin plays a key role in the process. But within the myriad twists and turns of the brain's intricate landscape, the exact pathways that the hormone travels to exert its influence have remained a mystery.
Neuroscientists at MIT have developed a powerful new class of tools to reversibly shut down brain activity using different colors of light.
A Journal of Addiction Medicine (JAM) study was cited in a recent Center for Substance Abuse Research (CESAR) series highlighting an emerging problem in addiction therapy: the diversion and misuse of the medication buprenorphine.
A newfound genetic marker promises to better predict warfarin dose in African-Americans, according to a study published online today in The Lancet. If confirmed in further studies, the finding may help to avert more of the bleeds and blood clots that come when a patient's starting dose misses the drug's narrow safety window.
› Verified 1 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
In investigating the complex neurocircuitry behind weight gain and glucose control, scientists have known that the hormone leptin plays a key role in the process. But within the myriad twists and turns of the brain's intricate landscape, the exact pathways that the hormone travels to exert its influence have remained a mystery.
Neuroscientists at MIT have developed a powerful new class of tools to reversibly shut down brain activity using different colors of light.
A Journal of Addiction Medicine (JAM) study was cited in a recent Center for Substance Abuse Research (CESAR) series highlighting an emerging problem in addiction therapy: the diversion and misuse of the medication buprenorphine.
A newfound genetic marker promises to better predict warfarin dose in African-Americans, according to a study published online today in The Lancet. If confirmed in further studies, the finding may help to avert more of the bleeds and blood clots that come when a patient's starting dose misses the drug's narrow safety window.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rubi Dominguez Rakel, AGACNP-BC Po Box 800022, Kansas City, MO 64180-0022 Ph: (800) 953-0104 | Rubi Dominguez Rakel, AGACNP-BC 14300 Orchard Pkwy, Westminster, CO 80023 Ph: (720) 627-3761 |
News Archive
In investigating the complex neurocircuitry behind weight gain and glucose control, scientists have known that the hormone leptin plays a key role in the process. But within the myriad twists and turns of the brain's intricate landscape, the exact pathways that the hormone travels to exert its influence have remained a mystery.
Neuroscientists at MIT have developed a powerful new class of tools to reversibly shut down brain activity using different colors of light.
A Journal of Addiction Medicine (JAM) study was cited in a recent Center for Substance Abuse Research (CESAR) series highlighting an emerging problem in addiction therapy: the diversion and misuse of the medication buprenorphine.
A newfound genetic marker promises to better predict warfarin dose in African-Americans, according to a study published online today in The Lancet. If confirmed in further studies, the finding may help to avert more of the bleeds and blood clots that come when a patient's starting dose misses the drug's narrow safety window.
› Verified 1 days ago
Mrs. Onna Klooster, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8510 Bryant St, 200, Westminster, CO 80031 Phone: 303-430-5560 Fax: 303-430-5565 | |
Ms. Mara Talin Minasian, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8300 Alcott St Ste 101, Westminster, CO 80031 Phone: 970-806-3695 | |
Tricia Lea Vath, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8510 Bryant St Ste 350, Westminster, CO 80031 Phone: 303-430-2640 Fax: 303-430-2625 | |
Leslie Marie Kennedy, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8510 Bryant St Ste 200, Westminster, CO 80031 Phone: 303-650-4460 Fax: 720-565-4130 | |
Courtney Williams, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12061 Tejon St Ste 600, Westminster, CO 80234 Phone: 303-457-0123 Fax: 303-252-4065 | |
Susan Mcmullen Jager, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8510 Bryant St Ste 200, Westminster, CO 80031 Phone: 303-650-4460 Fax: 720-565-4128 |